Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 271: A 24-year-old farmworker is brought to the emergency department after accidental exposure to parathion. Which of the following drugs can be given to reactivate his inhibited cholinesterases?

A. Atropine
B. Dimercaprol
C. Physostigmine
D. Pralidoxime (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Pralidoxime** Parathion is an **organophosphate (OP) compound** that acts by irreversibly binding to the active site of the enzyme acetylcholinesterase (AChE) via phosphorylation. This leads to an accumulation of acetylcholine and a cholinergic crisis. **Pralidoxime (2-PAM)** is a **cholinesterase reactivator**. It contains an oxime group with a high affinity for the phosphorus atom; it pulls the phosphate group away from the enzyme, thereby restoring its activity. *Note:* This must be administered before **"aging"** occurs (the chemical strengthening of the enzyme-toxin bond), typically within the first 24–48 hours. **Incorrect Options:** * **A. Atropine:** While Atropine is the first-line treatment for OP poisoning, it is a **muscarinic antagonist**. It blocks the *effects* of excess acetylcholine at the receptor level but does **not** reactivate the inhibited enzyme. * **B. Dimercaprol:** This is a chelating agent used in the treatment of heavy metal poisoning (e.g., arsenic, mercury, lead), not organophosphate toxicity. * **C. Physostigmine:** This is a reversible anticholinesterase. Giving it in OP poisoning would further inhibit the enzyme and worsen the cholinergic crisis. It is primarily used to treat atropine (anticholinergic) toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Atropinization:** The goal of treatment is to achieve "atropinization" (tachycardia, dilated pupils, and dry mouth/skin). * **Oximes in Carbamates:** Oximes are generally **not** indicated in carbamate poisoning (e.g., carbaryl) because the enzyme-carbamate bond is spontaneously reversible and oximes may even worsen the toxicity. * **Aging:** Once the enzyme-OP complex "ages," oximes are no longer effective. * **PAM vs. DAM:** Pralidoxime (PAM) does not cross the BBB well; **Diacetylmonoxime (DAM)** can cross the BBB and may help with central respiratory depression.

Question 272: Which of the following drugs is a neurotoxin that blocks the release of acetylcholine?

A. Hemicholinium
B. Vesamicol
C. Botulinum toxin (Correct Answer)
D. Metyrosine

Explanation: The synthesis, storage, and release of Acetylcholine (ACh) occur in distinct stages, each of which can be targeted by specific pharmacological agents. **1. Why Botulinum Toxin is Correct:** Botulinum toxin (produced by *Clostridium botulinum*) is a potent neurotoxin that acts at the presynaptic nerve terminal [2], [3]. It cleaves **SNARE proteins** (such as synaptobrevin or SNAP-25), which are essential for the docking and fusion of synaptic vesicles with the presynaptic membrane [2], [3]. By preventing this fusion, it **blocks the exocytotic release of Acetylcholine** into the synaptic cleft, leading to flaccid paralysis [3]. **2. Analysis of Incorrect Options:** * **A. Hemicholinium:** This drug blocks the **rate-limiting step** of ACh synthesis by inhibiting the high-affinity sodium-dependent **choline transporter (CHT)**, preventing the uptake of choline into the neuron [1]. * **B. Vesamicol:** This agent interferes with the **storage** of ACh [1]. It inhibits the **vesicle-associated transporter (VAT)**, preventing the transport of synthesized ACh into the synaptic vesicles [1]. * **C. Metyrosine:** This drug is unrelated to the cholinergic system. It inhibits **tyrosine hydroxylase**, the rate-limiting enzyme in **catecholamine (Dopamine/NE) synthesis**, and is used clinically in the management of pheochromocytoma. **High-Yield Clinical Pearls for NEET-PG:** * **Black Widow Spider Venom (Latrotoxin):** Acts opposite to Botulinum; it causes massive, explosive release of ACh. * **Therapeutic uses of Botox:** Strabismus, blephalospasm, achalasia cardia, spasticity, and cosmetic reduction of wrinkles. * **Lambert-Eaton Syndrome:** A paraneoplastic condition where antibodies attack P/Q-type voltage-gated calcium channels, also resulting in impaired ACh release.

Question 273: Indirect sympathomimetics can do which of the following?

A. Penetrate the blood brain barrier
B. Cause euphoria
C. Both of the above (Correct Answer)
D. None of the above

Explanation: **Explanation:** **1. Understanding Indirect Sympathomimetics:** Indirect sympathomimetics (e.g., Amphetamines, Tyramine, Cocaine) do not act directly on adrenergic receptors. Instead, they increase the concentration of endogenous catecholamines (Norepinephrine and Dopamine) in the synaptic cleft by either displacing them from storage vesicles or inhibiting their reuptake. **2. Why Option C is Correct:** * **Blood-Brain Barrier (BBB) Penetration:** Unlike direct-acting catecholamines (like Epinephrine or Norepinephrine), which are polar and do not cross the BBB, indirect agents like **Amphetamines** are non-polar and highly lipid-soluble. This allows them to readily cross the BBB. * **Euphoria:** Once in the CNS, these drugs trigger a massive release of **Dopamine** in the mesolimbic "reward" pathway (nucleus accumbens). This surge in dopamine is the primary mechanism behind the intense euphoria, increased alertness, and high addiction potential associated with these drugs. **3. Analysis of Incorrect Options:** * **Option A & B:** While both are individually true, they are incomplete. Since indirect sympathomimetics possess both pharmacokinetic (BBB penetration) and pharmacodynamic (euphoria) properties, "Both of the above" is the most accurate choice. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Amphetamines are used clinically for ADHD and Narcolepsy because of their CNS effects. * **The "Cheese Reaction":** Patients on MAO inhibitors who consume Tyramine (an indirect sympathomimetic found in aged cheese) can experience a hypertensive crisis due to massive norepinephrine release. * **Tachyphylaxis:** Indirect sympathomimetics often show "tachyphylaxis" (rapidly diminishing response) because they deplete the finite stores of norepinephrine in the nerve terminals.

Question 274: Which of the following acts as a depolarizing skeletal muscle relaxant?

A. Suxamethonium (Correct Answer)
B. Mivacurium
C. Pancuronium
D. Vecuronium

Explanation: ### Explanation **Correct Answer: A. Suxamethonium (Succinylcholine)** **Mechanism of Action:** Suxamethonium is the only clinically used **depolarizing neuromuscular blocker (dNMB)**. It acts as a nicotinic acetylcholine receptor (nAChR) agonist at the motor endplate. Unlike acetylcholine, it is not metabolized by acetylcholinesterase, leading to persistent depolarization. This results in initial muscle twitching (**fasciculations**) followed by flaccid paralysis because the sodium channels remain in an inactivated state, preventing further action potentials (Phase I block). **Analysis of Incorrect Options:** * **B, C, and D (Mivacurium, Pancuronium, Vecuronium):** These are all **Non-depolarizing neuromuscular blockers (ndNMBs)**. They act as competitive antagonists at the nAChR, preventing acetylcholine from binding. They do not cause initial depolarization or fasciculations. * **Mivacurium:** Short-acting benzylisoquinolinium. * **Vecuronium:** Intermediate-acting aminosteroid. * **Pancuronium:** Long-acting aminosteroid. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Suxamethonium is rapidly hydrolyzed by **Pseudocholinesterase** (Butyrylcholinesterase). Patients with atypical pseudocholinesterase experience prolonged apnea. * **Side Effects:** Hyperkalemia (caution in burn/trauma patients), muscle soreness, and increased intraocular/intragastric pressure. * **Malignant Hyperthermia:** Suxamethonium is a potent trigger (Treatment: **Dantrolene**). * **Reversal:** Phase I block is *potentiated* by anticholinesterases (like Neostigmine), whereas Phase II block (seen with high doses) can be reversed by them.

Question 275: Which of the following drugs does not cross the placental barrier?

A. Atropine
B. Glycopyrrolate (Correct Answer)
C. Physostigmine
D. Hyoscine hydrobromide

Explanation: The correct answer is **Glycopyrrolate**. [3] ### **1. Why Glycopyrrolate is Correct** The primary pharmacological concept here is the **chemical structure and ionization** of the drug. Glycopyrrolate is a **quaternary ammonium compound**. Because it is permanently charged (ionized) at physiological pH, it is highly polar and lipid-insoluble [1]. Consequently, it cannot easily cross lipid membranes, including the **blood-brain barrier (BBB)** and the **placental barrier** [1]. This makes it the drug of choice in obstetric anesthesia when an anticholinergic is needed without affecting the fetal heart rate. ### **2. Why the Other Options are Incorrect** * **Atropine & Hyoscine (Scopolamine):** These are **tertiary amines** [2]. Unlike quaternary compounds, tertiary amines are non-ionized and lipid-soluble. They easily cross the placenta and the BBB, which is why they can cause fetal tachycardia and central anticholinergic syndrome (confusion/sedation) in the mother. * **Physostigmine:** This is also a **tertiary amine** acetylcholinesterase inhibitor. It is specifically known for its ability to cross the BBB (used to treat atropine poisoning). Similarly, it crosses the placental barrier. In contrast, other carbamates like Neostigmine and Pyridostigmine are quaternary amines and do not cross. ### **3. High-Yield Clinical Pearls for NEET-PG** * **Mnemonic:** "Quaternary stays away" (from the brain and placenta). * **Clinical Use:** Glycopyrrolate is preferred over Atropine for premedication in pregnant patients to avoid **fetal tachycardia**. * **Reversal of Neuromuscular Blockade:** In anesthesia, Glycopyrrolate is paired with Neostigmine (both are quaternary) because their onset of action matches, and neither crosses the BBB, minimizing central side effects. * **Physostigmine vs. Neostigmine:** Always remember: **P**hysostigmine **P**enetrates the CNS; **N**eostigmine **N**o (does not).

Question 276: Bradycardia is common after injection of:

A. Midazolam
B. Succinylcholine (Correct Answer)
C. Dopamine
D. Isoprenaline

Explanation: **Explanation:** **Succinylcholine (Suxamethonium)** is a depolarizing neuromuscular blocker that acts as an agonist at nicotinic receptors. However, it also possesses significant structural similarity to acetylcholine, allowing it to stimulate **muscarinic (M2) receptors** in the sinoatrial (SA) node. This stimulation leads to parasympathetic effects, most notably **bradycardia**. This effect is particularly pronounced in children and when a second dose is administered shortly after the first in adults. **Analysis of Incorrect Options:** * **Midazolam (A):** A benzodiazepine used for induction and sedation. It typically causes minimal cardiovascular changes, though it may cause a slight decrease in systemic vascular resistance; it does not characteristically cause bradycardia. * **Dopamine (C):** At moderate to high doses, dopamine stimulates $\beta_1$-adrenergic receptors and triggers the release of norepinephrine, leading to **tachycardia** and increased contractility. * **Isoprenaline (D):** A potent non-selective $\beta$-agonist ($\beta_1$ and $\beta_2$). It causes significant **tachycardia** due to direct stimulation of the heart’s pacemaker cells. **High-Yield Clinical Pearls for NEET-PG:** * **Pre-treatment:** To prevent succinylcholine-induced bradycardia, **Atropine** (an anticholinergic) is often administered, especially in pediatric anesthesia. * **Hyperkalemia:** Succinylcholine causes a transient rise in serum potassium (approx. 0.5 mEq/L). It is contraindicated in patients with burns, crush injuries, or upper motor neuron lesions due to the risk of life-threatening hyperkalemia. * **Phase II Block:** Prolonged exposure to succinylcholine can lead to a "Phase II block," where the membrane repolarizes but becomes desensitized, resembling a non-depolarizing block.

Question 277: Which of the following is the most striking difference in the cardiac actions of epinephrine and norepinephrine?

A. Heart rate
B. Stroke volume
C. Cardiac output (Correct Answer)
D. Arrhythmias

Explanation: **Explanation:** The most striking difference between epinephrine (Epi) and norepinephrine (NE) lies in their effect on **Cardiac Output (CO)**. This difference is primarily due to their varying affinities for the **$\beta_2$ receptor**. 1. **Why Cardiac Output is the Correct Answer:** * **Epinephrine:** Acts on $\alpha_1, \beta_1,$ and $\beta_2$ receptors. At therapeutic doses, $\beta_2$-mediated vasodilation in skeletal muscle reduces Total Peripheral Resistance (TPR). This decrease in afterload, combined with $\beta_1$ stimulation (increased heart rate and contractility), leads to a **significant increase** in Cardiac Output. * **Norepinephrine:** Acts primarily on $\alpha_1$ and $\beta_1$ with negligible $\beta_2$ activity. It causes intense systemic vasoconstriction ($\alpha_1$), which significantly increases TPR and Mean Arterial Pressure. This high pressure triggers a potent **baroreceptor reflex** that overcomes the direct $\beta_1$ effect, resulting in bradycardia. Consequently, the CO remains **unchanged or slightly decreases**. 2. **Analysis of Incorrect Options:** * **Heart Rate:** While NE causes reflex bradycardia and Epi causes tachycardia, the net change in CO is more clinically significant and "striking" because it represents the total hemodynamic outcome. * **Stroke Volume:** Both drugs increase myocardial contractility via $\beta_1$ receptors, leading to an increase in stroke volume; thus, it is not the most distinguishing factor. * **Arrhythmias:** Both catecholamines are arrhythmogenic due to their $\beta_1$ agonist properties; there is no fundamental qualitative difference here. **High-Yield Clinical Pearls for NEET-PG:** * **Vasomotor Reversal of Dale:** If an $\alpha$-blocker (e.g., Phentolamine) is given before Epinephrine, the $\alpha$-mediated vasoconstriction is blocked, leaving only $\beta_2$-mediated vasodilation, causing a fall in BP. This does **not** occur with NE because it lacks significant $\beta_2$ action. * **Drug of Choice:** Epi is the DOC for **Anaphylactic Shock**; NE is the DOC for **Septic Shock**.

Question 278: All of the following are true about Glycopyrrolate except?

A. It is a muscarinic receptor antagonist.
B. It decreases oropharyngeal secretions.
C. It is a tertiary amine in structure. (Correct Answer)
D. It is used as a preanesthetic medication.

Explanation: **Explanation:** The correct answer is **C (It is a tertiary amine in structure)** because Glycopyrrolate is actually a **quaternary ammonium compound**. **1. Why Option C is the correct (false) statement:** In pharmacology, the chemical structure of an anticholinergic drug determines its pharmacokinetics. Tertiary amines (like Atropine or Scopolamine) are lipid-soluble and easily cross the blood-brain barrier (BBB), leading to central nervous system (CNS) side effects. In contrast, **Glycopyrrolate is a quaternary amine**, meaning it is polar/ionized at physiological pH. Consequently, it **does not cross the BBB** and lacks central effects like sedation or delirium. **2. Analysis of other options:** * **Option A:** Glycopyrrolate is a potent **muscarinic receptor antagonist** (anticholinergic) that blocks M1, M2, and M3 receptors. * **Option B:** It significantly **decreases oropharyngeal and tracheobronchial secretions**. It is more potent and longer-acting than atropine in this regard. * **Option D:** It is widely used as a **preanesthetic medication** to prevent intraoperative bradycardia and to minimize secretions, reducing the risk of aspiration during intubation. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Glycopyrrolate is preferred over Atropine when reversing neuromuscular blockade (with Neostigmine) because its onset matches Neostigmine better and it causes less initial tachycardia. * **CNS Safety:** Because it doesn't cross the BBB, it is the preferred anticholinergic for elderly patients to avoid postoperative cognitive dysfunction. * **Other Quaternary Amines:** Remember the mnemonic **"B-I-G"** (Ipratropium, Glycopyrrolate, Benztropine is tertiary but *Butylscopolamine* is quaternary) for drugs with minimal CNS penetration.

Question 279: All of the following are therapeutic uses of prazosin, except?

A. Peripheral vascular disease
B. Phaeochromocytoma
C. Lupus Erythematosus (Correct Answer)
D. Scorpion sting

Explanation: **Explanation:** Prazosin is a highly selective **Alpha-1 ($\alpha_1$) adrenergic blocker**. It acts by inhibiting post-synaptic $\alpha_1$ receptors, leading to potent vasodilation of both arterioles and veins. **Why Lupus Erythematosus is the Correct Answer:** Lupus Erythematosus (SLE) is an autoimmune connective tissue disorder. Prazosin has no role in its management. In fact, certain drugs like Hydralazine, Procainamide, and Isoniazid are known to *cause* Drug-Induced Lupus, but Prazosin is neither a treatment nor a common cause. **Analysis of Incorrect Options (Therapeutic Uses):** * **Peripheral Vascular Disease (PVD):** By blocking $\alpha_1$ receptors, Prazosin causes vasodilation, which helps improve blood flow in conditions like Raynaud’s phenomenon. * **Phaeochromocytoma:** While Phenoxybenzamine (non-selective) is the drug of choice for preoperative management, selective $\alpha_1$ blockers like Prazosin are used to control hypertension and prevent hypertensive crises during surgery. * **Scorpion Sting:** In India (specifically *Mesobuthus tamulus* stings), Prazosin is the **drug of choice**. It counteracts the massive release of catecholamines ("autonomic storm") that leads to pulmonary edema and hypertension. **NEET-PG High-Yield Pearls:** 1. **First Dose Phenomenon:** Prazosin can cause marked postural hypotension and syncope with the initial dose. Advise patients to take the first dose at bedtime. 2. **BPH:** Prazosin (and Tamsulosin) relaxes the smooth muscles of the bladder neck and prostate, improving urine flow in Benign Prostatic Hyperplasia. 3. **PTSD:** Prazosin is uniquely used to reduce trauma-related nightmares in Post-Traumatic Stress Disorder.

Question 280: Black widow spider toxin is known to cause what effect on neurotransmitter release?

A. Excess release of Acetylcholine (Correct Answer)
B. Decreased release of Acetylcholine
C. Inhibition of Acetylcholine synthesis
D. Blocking of Acetylcholine transport into synaptic vesicles

Explanation: **Explanation:** The toxin produced by the Black Widow spider is known as **$\alpha$-latrotoxin**. This potent neurotoxin acts by binding to specific receptors (neurexins and latrophilins) on the presynaptic nerve terminal. This binding triggers a massive, uncontrolled influx of $Ca^{2+}$ and creates pores in the membrane, leading to the **excessive release (exocytosis) of Acetylcholine (ACh)** and other neurotransmitters. **Why the correct answer is right:** * **Option A:** $\alpha$-latrotoxin causes the depletion of synaptic vesicles by forcing their fusion with the presynaptic membrane. This results in a "cholinergic storm," leading to clinical symptoms like severe muscle cramps, abdominal rigidity, and autonomic instability. **Why the incorrect options are wrong:** * **Option B:** Decreased release is characteristic of **Botulinum toxin**, which cleaves SNARE proteins, preventing vesicle fusion. * **Option C:** Inhibition of ACh synthesis is the mechanism of **Hemicholinium**, which blocks the rate-limiting step (choline uptake). * **Option D:** Blocking transport into vesicles is the mechanism of **Vesamicol**, which inhibits the VAT (Vesicle Associated Transporter). **High-Yield Clinical Pearls for NEET-PG:** * **Latrotoxin vs. Botulinum:** They are physiological opposites. Latrotoxin causes *spastic* paralysis/cramps (excess ACh), while Botulinum causes *flaccid* paralysis (deficient ACh). * **Clinical Presentation:** The syndrome is called **Latrodectism**. A classic sign is "facies latrodectismica" (facial grimacing and edema). * **Management:** Treatment is supportive (analgesics and benzodiazepines for muscle spasms); specific antivenom is reserved for severe cases.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free